Mid-term report 2013 - The European LeukemiaNet
Mid-term report 2013 - The European LeukemiaNet
Mid-term report 2013 - The European LeukemiaNet
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>European</strong> <strong>LeukemiaNet</strong> <strong>Mid</strong><strong>term</strong> Report, 08-RNP-071<br />
Author(s)<br />
Title<br />
Rego EM, Kim HT, Ruiz-Argüelles GJ,<br />
Undurraga MS, Uriarte Mdel R, Jacomo RH,<br />
Gutiérrez-Aguirre H, Melo RA, Bittencourt R,<br />
Pasquini R, Pagnano K, Fagundes EM,<br />
Chauffaille Mde L, Chiattone CS, Martinez L,<br />
Meillón LA, Gómez-Almaguer D, Kwaan HC,<br />
Garcés-Eisele J, Gallagher R, Niemeyer CM, Improving acute promyelocytic<br />
Schrier SL, Tallman M, Grimwade D, Ganser leukemia (APL) outcome in developing<br />
A, Berliner N, Ribeiro RC, Lo-Coco F, countries through networking, results of<br />
Löwenberg B, Sanz MA.<br />
Simonsson, Bengt; Gedde-Dahl, Tobias;<br />
Markevarn, Berit; et al.<br />
Skiada A, Lanternier F, Groll AH, Pagano L,<br />
Zimmerli S, Herbrecht R, Lortholary O,<br />
Petrikkos GL; <strong>European</strong> Conference on<br />
Infections in Leukemia.<br />
Type of<br />
Publication<br />
the International Consortium on APL. article Blood.<br />
Combination of pegylated IFN-alpha 2b<br />
with imatinib increases molecular<br />
response rates in patients with low- or<br />
in<strong>term</strong>ediate-risk chronic myeloid<br />
leukemia article BLOOD<br />
Diagnosis and treatment of<br />
mucormycosis in patients with<br />
hematological malignancies: guidelines<br />
from the 3rd <strong>European</strong> Conference on<br />
Infections in Leukemia (ECIL 3). article Haematologica.<br />
If Other,<br />
specify In (journal title…) Volume, pages, year…<br />
Smith, Matthew L.; Hills, Robert K.;<br />
Grimwade, David<br />
Independent prognostic variables in<br />
acute myeloid leukaemia review BLOOD REVIEWS<br />
BCR-ABL kinase domain mutation<br />
analysis in chronic myeloid leukemia<br />
Soverini S, Hochhaus A, Nicolini FE, Gruber patients treated with tyrosine kinase<br />
F, Lange T, Saglio G, Pane F, Müller MC, Ernst inhibitors: recommendations from an<br />
T, Rosti G, Porkka K, Baccarani M, Cross NC, expert panel on behalf of <strong>European</strong><br />
Martinelli G.<br />
<strong>LeukemiaNet</strong>. review Blood.<br />
Soverini, Simona; Rosti, Gianantonio;<br />
Iacobucci, Ilaria; et al.<br />
Soverini, Simona; Vitale, Antonella; Poerio,<br />
Angela; et al.<br />
Te Raa GD, Malcikova J, Pospisilova S,<br />
Trbusek M, Mraz M, Le Garff-Tavernier M,<br />
Merle-Béral H, Lin K, Pettitt AR, Merkel O,<br />
Stankovic T, van Oers MH, Eldering E,<br />
Stilgenbauer S, Zenz T, Kater AP; on behalf<br />
of the <strong>European</strong> Research Initiative on CLL<br />
(ERIC).<br />
Choosing the Best Second-Line Tyrosine<br />
Kinase Inhibitor in Imatinib-Resistant<br />
Chronic Myeloid Leukemia Patients<br />
Harboring Bcr-Abl Kinase Domain<br />
Mutations: How Reliable Is the IC50? article ONCOLOGIST<br />
Philadelphia-positive acute<br />
lymphoblastic leukemia patients<br />
already harbor BCR-ABL kinase domain<br />
mutations at low levels at the time of<br />
diagnosis<br />
article<br />
Overview of available p53 function tests<br />
in relation to TP53 and ATM gene<br />
alterations and chemoresistance in<br />
chronic lymphocytic leukemia. article Leuk Lymphoma.<br />
van de Loosdrecht AA, Ireland R, Kern W,<br />
Della Porta MG, Alhan C, Balleisen JS,<br />
Bettelheim P, Bowen DT, Burbury K,<br />
Eidenschink L, Cazzola M, Chu SS, Cullen M,<br />
Cutler JA, Dräger AM, Feuillard J, Fenaux P,<br />
Font P, Germing U, Haase D, Hellström-<br />
Lindberg E, Johansson U, Kordasti S, Loken<br />
MR, Malcovati L, te Marvelde JG, Matarraz S,<br />
Milne T, Moshaver B, Mufti GJ, Nikolova V,<br />
Ogata K, Oelschlaegel U, Orfao A,<br />
Ossenkoppele GJ, Porwit A, Platzbecker U,<br />
Preijers F, Psarra K, Richards SJ, Subirá D,<br />
Seymour JF, Tindell V, Vallespi T, Valent P,<br />
Rationale for the clinical application of<br />
flow cytometry in patients with<br />
myelodysplastic syndromes: position<br />
paper of an International Consortium<br />
van der Velden VH, Wells DA, de Witte TM, and the <strong>European</strong> <strong>LeukemiaNet</strong> Working<br />
Zettl F, Béné MC, Westers TM.<br />
Group. article Leuk Lymphoma.<br />
c-Myb and its target Bmi1 are required<br />
Waldron, T.; De Dominici, M.; Soliera, A. R.; for p190BCR/ABL leukemogenesis in<br />
et al.<br />
mouse and human cells article LEUKEMIA<br />
Westers TM, Ireland R, Kern W, Alhan C,<br />
Balleisen JS, Bettelheim P, Burbury K, Cullen<br />
M, Cutler JA, Della Porta MG, Dräger AM,<br />
Feuillard J, Font P, Germing U, Haase D,<br />
Johansson U, Kordasti S, Loken MR,<br />
Malcovati L, te Marvelde JG, Matarraz S,<br />
Milne T, Moshaver B, Mufti GJ, Ogata K, Standardization of flow cytometry in<br />
Orfao A, Porwit A, Psarra K, Richards SJ, myelodysplastic syndromes: a <strong>report</strong><br />
Subirá D, Tindell V, Vallespi T, Valent P, van from an international consortium and<br />
der Velden VH, de Witte TM, Wells DA, Zettl the <strong>European</strong> <strong>LeukemiaNet</strong> Working<br />
F, Béné MC, van de Loosdrecht AA. Group. article Leukemia.<br />
Establishment and Validation of<br />
Analytical Reference Panels for the<br />
Standardization of Quantitative BCR-<br />
ABL1 Measurements on the<br />
White et al.,<br />
International Scale. article Clin Chem.<br />
White et al.,<br />
Zenz T, Vollmer D, Trbusek M, Smardova J,<br />
Benner A, Soussi T, Helfrich H, Heuberger M,<br />
Hoth P, Fuge M, Denzel T, Häbe S, Malcikova<br />
J, Kuglik P, Truong S, Patten N, Wu L, Oscier<br />
D, Ibbotson R, Gardiner A, Tracy I, Lin K,<br />
Pettitt A, Pospisilova S, Mayer J, Hallek M,<br />
Döhner H, Stilgenbauer S; <strong>European</strong><br />
Research Initiative on CLL (ERIC).<br />
Peer-reviewed<br />
ESF acknow-ledged<br />
Open Access (OA)<br />
If OA,<br />
enter<br />
web<br />
address<br />
Funde<br />
d by<br />
ELN<br />
Recomm Meeti<br />
endation ESF ng<br />
Pubme<br />
d<br />
recher<br />
che<br />
<strong>2013</strong> Mar 14;121(11):1935-43.<br />
doi: 10.1182/blood-2012-08-<br />
449918. Epub <strong>2013</strong> Jan 14. x<br />
Volume: 118 Issue: 12<br />
Pages: 3228-3235 DOI:<br />
10.1182/blood-2011-02-<br />
336685 Published: SEP 22<br />
2011 x<br />
<strong>2013</strong> Apr;98(4):492-504. doi:<br />
10.3324/haematol.2012.06511<br />
0. Epub 2012 Sep 14. x<br />
Volume: 25 Issue: 1 Pages:<br />
39-51 DOI:<br />
10.1016/j.blre.2010.10.002<br />
Published: JAN 2011<br />
x<br />
2011 Aug 4;118(5):1208-15.<br />
doi: 10.1182/blood-2010-12-<br />
326405. Epub 2011 May 11.<br />
Review. x x<br />
Volume: 16 Issue: 6 Pages:<br />
868-876 DOI:<br />
10.1634/theoncologist.2010-<br />
0388 Published: 2011 x<br />
Volume: 96 Issue: 4 Pages:<br />
HAEMATOLOGICA-THE 552-557 DOI:<br />
HEMATOLOGY<br />
JOURNAL<br />
10.3324/haematol.2010.03417<br />
3 Published: APR 2011 x<br />
<strong>2013</strong> Apr 24. [Epub ahead of<br />
print]<br />
<strong>2013</strong> Mar;54(3):472-5. doi:<br />
10.3109/10428194.2012.71834<br />
1. Epub 2012 Sep 14. x x<br />
Volume: 26 Issue: 4 Pages:<br />
644-653 DOI:<br />
10.1038/leu.2011.264<br />
Published: APR 2012<br />
x<br />
2012 Jul;26(7):1730-41. doi:<br />
10.1038/leu.2012.30. Epub<br />
2012 Feb 6 x x x x<br />
<strong>2013</strong> Mar 7. [Epub ahead of<br />
print]<br />
x<br />
Establishment of the first World Health<br />
Organization International Genetic<br />
Reference Panel for quantitation of BCR-<br />
ABL mRNA. article Blood. 2010 Nov 25;116(22):e111-7. x<br />
TP53 mutation profile in chronic<br />
lymphocytic leukemia: evidence for a<br />
disease specific profile from a<br />
comprehensive analysis of 268<br />
mutations. article Leukemia.<br />
A <strong>European</strong> consensus <strong>report</strong> on blood<br />
Zini G, Bain B, Bettelheim P, Cortez J, cell identification: <strong>term</strong>inology utilized<br />
d'Onofrio G, Faber E, Haferlach T, Kacirkova and morphological diagnosis<br />
P, Lewandowski K, Matutes E, Maynadié M, concordance among 28 experts from 17<br />
Meletis J, Petersen BL, Porwit A, Terpos E, countries within the <strong>European</strong><br />
Tichelli A, Vallespí T, Woessner S, Bennett J, <strong>LeukemiaNet</strong> network WP10, on behalf<br />
Bene MC.<br />
of the ELN Morphology Faculty. article Br J Haematol.<br />
2010 Dec;24(12):2072-9. doi:<br />
10.1038/leu.2010.208. Epub<br />
2010 Sep 23. x<br />
2010 Nov;151(4):359-64. doi:<br />
10.1111/j.1365-<br />
2141.2010.08366.x. (Meeting<br />
war 2011)<br />
x<br />
x<br />
32